The global smart stethoscope market size was valued at USD 56.1 million in 2023 and is projected to grow at a CAGR of 7.0% from 2024 to 2030. The growing trend towards telemedicine and remote patient monitoring has significantly influenced the adoption of smart stethoscopes. Healthcare providers are increasingly seeking tools to monitor patients outside traditional clinical settings. Smart stethoscopes enable physicians to conduct remote examinations by capturing high-quality audio recordings of heartbeats and lung sounds, which can be transmitted securely for analysis. This capability improves patient access to care and enhances healthcare delivery systems' efficiency, making smart stethoscopes an attractive option for modern medical practices.
According to the World Health Organization (WHO), CVDs remain the leading cause of death globally, accounting for approximately 17.9 million deaths each year. This alarming statistic highlights a significant patient pool that requires effective monitoring and diagnosis, which drives demand for advanced diagnostic tools like smart stethoscopes. These devices enhance auscultation, allowing healthcare professionals to detect heart sounds more accurately and efficiently, thereby facilitating early diagnosis and treatment.
The rapid technological advancement has significantly contributed to the growth of the smart stethoscope market. Innovations such as artificial intelligence (AI) integration, noise-cancellation features, and enhanced sound amplification have transformed traditional stethoscopes into sophisticated diagnostic tools. AI-enabled smart stethoscopes analyze heart and lung sounds with greater precision, reducing misdiagnosis rates that are prevalent with conventional devices. As healthcare providers increasingly adopt these technologies to improve patient outcomes, the demand for smart stethoscopes is expected to rise correspondingly.
The COVID-19 pandemic has accelerated the adoption of telemedicine and remote patient monitoring solutions, including smart stethoscopes. With healthcare systems overwhelmed by the pandemic, there has been a push towards minimizing in-person visits while still providing quality care. Smart stethoscopes facilitate remote consultations by allowing healthcare professionals to listen to patients’ heart and lung sounds from a distance, thus ensuring safety during examinations. This shift towards telehealth services has created a favorable environment for smart stethoscope manufacturers as they cater to new demands arising from changing healthcare practices.
The cardiovascular segment dominated the market and accounted for a share of 28.9% in 2023. The increasing prevalence of cardiovascular diseases globally has amplified the demand for advanced diagnostic tools. Cardiovascular diseases, including heart attacks, strokes, and hypertension, are leading causes of mortality worldwide. As the number of patients needing regular monitoring and early diagnosis rises, smart stethoscopes offer a promising solution with enhanced capabilities for capturing and analyzing heart sounds. These devices can provide more accurate and comprehensive data than traditional stethoscopes, facilitating early detection and better managing cardiovascular conditions.
The neonatal segment is anticipated to grow significantly at a CAGR over the forecast period. Smart stethoscopes are advanced medical devices integrating digital technology with traditional auscultation methods, allowing for enhanced monitoring and diagnostics. In neonatology, where timely and accurate assessment is critical, these devices offer real-time data transmission, sound amplification, and connectivity with electronic health records (EHR). The increasing prevalence of neonatal conditions requiring immediate attention drives the demand for innovative tools such as smart stethoscopes.
Hospitals accounted for the largest market revenue share in 2023. Hospitals increasingly adopt advanced medical technologies to enhance diagnostic accuracy and improve patient outcomes. Smart stethoscopes, equipped with high-fidelity microphones, digital recording capabilities, and real-time data analysis, offer superior diagnostic precision compared to traditional stethoscopes. This technological advancement allows healthcare professionals in hospitals to detect subtle abnormalities in heart and lung sounds that might otherwise go unnoticed, leading to more accurate diagnoses and better patient care.
Home healthcare is anticipated to register the fastest CAGR over the forecast period. Chronic conditions such as heart disease, hypertension, and respiratory disorders often require regular monitoring and management. As patients increasingly prefer to receive care at home rather than in clinical settings, there is a rising demand for advanced medical devices that can facilitate home-based monitoring. Smart stethoscopes offer a solution by providing accurate auscultation and real-time data transmission, enabling patients to effectively manage their health conditions from the comfort of their homes.
The distributors segment accounted for the largest market revenue share in 2023. As new hospitals, clinics, and specialized medical centers are established, the need for medical equipment, including smart stethoscopes, rises correspondingly. Distributors are pivotal in ensuring these healthcare facilities have the latest diagnostic tools. The growth in healthcare establishments creates a broader market for distributors to serve, thereby driving their business and expanding their market presence.
E-commerce is projected to grow at the fastest CAGR over the forecast period. The convenience and accessibility of e-commerce platforms allow healthcare professionals and institutions to easily browse, compare, and purchase smart stethoscopes without the need to visit physical stores. This shift is particularly advantageous for purchasing advanced medical equipment, such as smart stethoscopes, which can be complex and require detailed specifications and comparisons. E-commerce platforms provide comprehensive product information and customer reviews, facilitating informed decision-making and driving the adoption of smart stethoscopes through online channels.
North America smart stethoscope market dominated the market and accounted for a market revenue share of 35.3% in 2023 owing to the rising prevalence of chronic diseases, particularly cardiovascular and respiratory ailments. The region's aging population and increased healthcare spending have created a strong demand for advanced diagnostic tools that can improve early detection and monitoring. Additionally, as a global leader in medical technology, the U.S. has a strong ecosystem for developing and adopting innovative solutions like smart stethoscopes. This, combined with government initiatives supporting digital health, has further accelerated North America's market growth.
The U.S. smart stethoscope market is anticipated to grow rapidly over the forecast period. The increasing focus on preventive healthcare and personalized medicine further drives the growth of the smart stethoscope market in the U.S. There is a growing emphasis on early detection and personalized care to prevent disease progression and tailor treatment to individual patients. Smart stethoscopes provide valuable insights through continuous monitoring and detailed analysis of patients’ health metrics. This capability supports the U.S. healthcare system’s shift towards preventive and personalized approaches, driving the demand for smart stethoscopes as healthcare providers seek to offer proactive and individualized care.
Europe smart stethoscope market was identified as a lucrative region in 2023. European countries have well-established healthcare systems and are increasingly integrating innovative medical devices into their practices. The adoption of smart stethoscopes aligns with Europe’s focus on enhancing diagnostic accuracy and efficiency in patient care. As healthcare providers across the continent seek to modernize their diagnostic tools, the demand for smart stethoscopes is rising, driving market expansion.
The UK smart stethoscope market is anticipated to grow significantly over the forecast period. The UK's commitment to integrating advanced technologies into its National Health Service (NHS) to improve diagnostic accuracy and patient care proliferates the market. The NHS, as one of the world's largest publicly funded health services, is increasingly adopting innovative medical devices to enhance its capabilities. Smart stethoscopes, with their advanced features such as real-time data transmission and detailed sound analysis, align with the NHS's goals of modernization and efficiency.
Asia Pacific smart stethoscope market is anticipated to register the fastest CAGR over the forecast period. As the population increases, the prevalence of chronic diseases and health conditions that require regular monitoring and medical attention rises correspondingly. This surge in healthcare needs drives the adoption of advanced medical devices, including smart stethoscopes, which offer enhanced functionalities such as digital auscultation, data storage, and connectivity to mobile applications, making them essential tools for healthcare professionals who need to manage larger patient volumes efficiently.
China smart stethoscope market is anticipated to grow rapidly over the forecast period. China’s aging population further accelerates the demand for smart stethoscopes. According to the World Health Organization (WHO), the proportion of individuals aged 60 and above is increasing rapidly, projected to reach over 25% of the total population by 2040. This demographic shift is accompanied by a higher incidence of age-related health issues, necessitating advanced diagnostic tools for effective monitoring and care. Smart stethoscopes, with their sophisticated technology, are well-suited to meet the needs of an aging population by providing detailed health assessments and supporting early detection of potential health problems.
Some of the key companies in the smart stethoscope market include 3M, Thinklabs Medical LLC, HD Medical, Inc., Eko Health, Inc., and others.
3M offers a range of smart stethoscopes designed to enhance healthcare professionals' diagnostic capabilities. Their devices often incorporate advanced features such as noise reduction technology, digital sound amplification, and customizable listening modes. These features allow clinicians to hear subtle heart and lung sounds more clearly, aiding in diagnosing various conditions.
Thinklabs Medical LLC offers Thinklabs One, a smart stethoscope that integrates advanced audio technology with digital capabilities. This device allows healthcare professionals to listen to heart and lung sounds with exceptional clarity and detail, significantly enhancing diagnostic accuracy.
The following are the leading companies in the smart stethoscope market. These companies collectively hold the largest market share and dictate industry trends.
View a comprehensive list of companies in the Smart Stethoscope Market
In June 2024, Eko Health, Inc. secured USD 41 million in funding to enhance its development of AI-powered smart stethoscopes. This investment will enable the company to expand its product offerings and improve the capabilities of its existing devices, which are designed to assist healthcare professionals in diagnosing cardiovascular conditions more effectively.
In July 2023, Astellas Pharma Inc. entered into a strategic agreement with Eko Health, Inc. to integrate the advanced Eko CORE 500 digital stethoscope into Z1608, a non-invasive device-DTx to improve care for heart failure patients. By utilizing the digital stethoscope’s capabilities, clinicians can gather critical cardiovascular data remotely, facilitating timely interventions and personalized patient care plans.
Report Attribute |
Details |
Market size value in 2024 |
USD 59.9 million |
Revenue forecast in 2030 |
USD 90.1 million |
Growth rate |
CAGR of 7.0% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, distribution channel, end use, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, Germany, UK, France, Germany, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Saudi Arabia, UAE, Kuwait, and South Africa |
Key companies profiled |
3M, Thinklabs Medical LLC, HD Medical, Inc., Eko Health, Inc., eKuore, M3DICINE Pty Ltd., Sonavi Labs, Steth IO, Medline Industries |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the smart stethoscope market report based on application, distribution channel, end use, and region:
Application Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular
Neonatal
Pediatric
Fetal
Teaching
Others
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Distributors
E-commerce
Direct Purchase
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Home Healthcare
Hospitals
Clinics (Individual Clinics)
Nurse Practitioners
EMT/ First Responders
Veterinary
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."